Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Allos nets $48.9mm in private placement to Warburg Pincus

Executive Summary

Cancer drug company Allos Therapeutics netted $48.9mm through the private placement of 2.35mm Series A exchangeable preferred shares priced at $22.10 apiece to Warburg Pincus Private Equity (2.2mm shares) and FrontPoint Healthcare Horizons (90k shares). After 15 months, each preferred share will automatically convert into ten common shares.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies